http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2527335-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd1d44888f5b41142d83de455096387 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22d194a22f2f52ca15b35a33380002a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63b569ba49aba9f97bff92216dcd69f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528f44fa03df67d1234a442f3342e3a0 |
| publicationDate | 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2527335-A1 |
| titleOfInvention | Triazole compounds as anti-inflammatory agents |
| abstract | The present invention relates to a compound of formula 1. or 2n nwherein R 1 represents straight-chain or branched C 2 -C 8 alkyl, C 2 -C 8 alkenyl, optionally substituted by at least one substituent selected from the group consisting of hydroxyl, amino or C 1 -C 6 alkyl amino group, or C 2 -C 4 alkynyl, optionally substituted by at least one substituent selected from the group consisting of hydroxyl, amino or C 1 -C 6 alkyl amino group; and R 2 represents hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 alkylcarbonyl, di(C 1 -C 6- alkyl)aminomethyl, C 3 -C 6 heterocyclylmethyl or arylaminomethyl, wherein the aryl group is optionally substituted by at least one substituent selected from the group consisting of halogens and C 1 -C 6 alkoxy as well as associated pharmaceutical compositions and uses of the compound or composition in therapy, in particular for the treatment of a disorder or a disease susceptible to inhibition of COX-2. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3653611-A1 |
| priorityDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.